Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function

Nature Immunology

Volumn 10, Issue 3, 2009, Pages 273-280

  Rub, Abdur ^a   Dey, Ranadhir ^a   Jadhav, Meenakshi ^a   Kamat, Rohan ^b   Chakkaramakkil, Santhosh ^b   Majumdar, Subrata ^c   Mukhopadhyaya, Robin ^b   Saha, Bhaskar ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b Research and Education in Cancer ACTREC   (India)

^c BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 12; PROTEIN KINASE LYN; PROTEIN KINASE SYK; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; IMMUNOLOGY; MACROPHAGE; METABOLISM; PARASITOLOGY; PHOSPHORYLATION; SKIN LEISHMANIASIS;

ANIMALS; ANTIGENS, CD40; CELLS, CULTURED; CHOLESTEROL; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 60749115540     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1705     Document Type: Article

References (55)

1. Li, L., Elliott, J.F. & Mosmann, T.R. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153, 3967-3978 (1994).
2. Snapper, C.M. & Paul, W.E. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944-947 (1987).
3. Mond, J.J., Carman, J., Sarma, C., Ohara, J. & Finkelman, F.D. Interferon-γ suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J. Immunol. 137, 3534-3537 (1986).
4. Krummel, M.F. & Allison, J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465 (1995).
5. Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550 (1996).
6. Grammer, A.C. & Lipsky, P.E. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv. Immunol. 76, 61-178 (2000).
7. Bishop, G.A., Moore, C.R., Xie, P., Stunz, L.L. & Kraus, Z.J. TRAF proteins in CD40 signaling. Adv. Exp. Med. Biol. 597, 131-151 (2007).
8. Bishop, G.A., Hostager, B.S. & Brown, K.D. Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. J. Leukoc. Biol. 72, 19-23 (2002).
9. Kamanaka, M. et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-281 (1996).
10. Soong, L. et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273 (1996).
11. Campbell, K.A. et al. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-289 (1996).
12. Mathur, R.K., Awasthi, A., Wadhone, P., Ramanamurthy, B. & Saha, B. Reciprocal CD40 signals through p38MAPK and Erk-1/2 induce counteracting immune responses. Nat. Med. 10, 540-544 (2004); erratum in Nat. Med. 10, 755 (2004).
13. Chakraborty, D. et al. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J. Immunol. 175, 3214-3224 (2005).
14. Vidalain, P.O. et al. CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J. 19, 3304-3313 (2000).
15. Hancock, J.F. & Patron, R.G. Ras plasma membrane signaling platforms. Biochem. J. 389, 1-11 (2005).
16. Nicolau, D.V. Jr., Burrage, K., Parton, R.G. & Hancock, J.F. Identifying optimal lipid raft characteristics required to promote nanoscale protein-protein interactions on the plasma membrane. Mol. Cell. Biol. 26, 313-323 (2006).
17. Hancock, J.F. Lipid rafts: Contentious only from simplistic standpoints. Nat. Rev. Mol. Cell Biol. 7, 456-462 (2006).
18. Pontier, S.M. et al. Cholesterol-dependent separation of the β2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J. Biol. Chem. 283, 24659-24672 (2008).
19. Frank, C. et al. Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp. Neurol. 212, 407-414 (2008).
20. Pucadyil, T.J. & Chattopadhyay, A. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin (1A) receptor in the plasma membrane of living cells. Biochim. Biophys. Acta 1768 655-668 (2007).
21. Xia, M. et al. Anthocyanin prevents CD40-activated proinflammatory signaling in endothelial cells by regulating cholesterol distribution. Arterioscler. Thromb. Vasc. Biol. 27, 519-524 (2007).
22. McConnell, H.M. & Radhakrishnan, A. Condensed complexes of cholesterol and phospholipids. Biochim. Biophys. Acta 1610, 159-173 (2003).
23. McConnell, H.M. & Vrljic, M. Liquid-liquid immiscibility in membranes. Annu. Rev. Biophys. Biomol. Struct. 32, 469-492 (2003).
24. Huang, J. & Feigenson, G.W. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys. J. 76, 2142-2157 (1999).
25. Pandit, S.A., Jakobsson, E. & Scott, H.L. Simulation of the early stages of nano-domain formation in mixed bilayers of sphingomyelin, cholesterol, and dioleylphosphatidylcholine. Biophys. J. 87, 3312-3322 (2004).
26. Ipsen, J.H. et al. Phase equilibria in the phosphatidylcholine-cholesterol system. Biochim. Biophys. Acta 905, 162-172 (1987).
27. Pullen, S.S. et al. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 38, 10168-10177 (1999).
28. Awasthi, A. et al. CD40 signaling is impaired in L. major infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. J. Exp. Med. 197, 1037-1043 (2003).
29. Pullen, S.S. et al. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37, 11836-11845 (1998).
30. Sefton, B.M. & Taddie, J.A. Role of tyrosine kinases in lymphocyte activation. Curr. Opin. Immunol. 6, 372-379 (1994).
31. Waiczies, S. et al. Atorvastatin induces T cell anergy via phosphorylation of ERK1. J. Immunol. 174, 5630-5635 (2005).
32. Gegg, M.E. et al. Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction. J. Immunol. 174, 2327-2335 (2005).
33. Murugaiyan, G., Agrawal, R., Mishra, G.C., Mitra, D. & Saha, B. Functional dichotomy in CD40 reciprocally regulates effector T cell functions. J. Immunol. 177, 6642-6649 (2006).
34. Murugaiyan, G., Agrawal, R., Mishra, G.C., Mitra, D. & Saha, B. Differential CD40/CD40L expression results in counteracting anti-tumor immune responses. J. Immunol. 178, 2047-2055 (2007).
35. Toubi, E. & Shoenfeld, Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37, 457-464 (2004).
36. Quezada, S.A., Jarvinen, L.Z., Lind, E.F. & Noelle, R.J. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22, 307-328 (2004).
37. Yamada, A. & Sayegh, M.H. The CD154-CD40 costimulatory pathway in transplantation. Transplantation 73, S36-S39 (2002).
38. Lichtenberg, D., Goni, F.M. & Heerklotz, H. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem. Sci. 30, 430-436 (2005).
39. Veiga, M.P. et al. Interaction of cholesterol and sphingomyelin in mixed membranes containing phosphatidylcholine, studied by spin-label ESR and IR spectroscopies. A possible stabilization of gel-phase sphingolipid domains by cholesterol. Biochemistry 40, 2614-2622 (2001).
40. Scheiffele, P. et al. Interaction of influenza virus haemagglutinin with sphingolipid cholesterol membrane domains via its transmembrane domain. EMBO J. 16, 5501-5508 (1997).
41. Bock, J. & Gulbins, E. The transmembranous domain of CD40 determines CD40 partitioning into lipid rafts. FEBS Lett. 534, 169-174 (2003).
42. Guigas, G. & Weiss, M. Influence of hydrophobic mismatching on membrane protein diffusion. Biophys. J. 95, L25-L27 (2008).
43. Groux, H. et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162, 1723-1729 (1999).
44. Hagenbaugh, A. et al. Altered immune responses in interleukin 10 transgenic mice. J. Exp. Med. 185, 2101-2110 (1997).
45. Fiorentino, D.F., Bond, M.W. & Mosmann, T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095 (1989).
46. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
47. Lal, C.S. et al. Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis. Clin. Chim. Acta 382, 151-153 (2007).
48. Shrivastava, S. & Chattopadhyay, A. Influence of cholesterol and ergosterol on membrane dynamics using fluorescent probes. Biochem. Biophys. Res. Commun. 356, 705-710 (2007).
49. Ni, C.Z. et al. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. USA. 97, 10395-10399 (2000).
50. London, E. & Brown, D.A. Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim. Biophys. Acta 1508, 182-195 (2000).
51. Hostager, B.S. et al. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 275, 15392-15398 (2000).
52. Pei, Y. & Tuschl, T. On the art of identifying effective and specific siRNAs. Nat. Methods 3, 670-676 (2006).
53. Nishitsuji, H. et al. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes Infect. 6, 76-85 (2004).
54. Santhosh, C.V., Tamhane, M.C., Kamat, R.H., Patel, V.V. & Mukhopadhyaya, R. A Lentiviral vector with novel multiple cloning sites: Stable transgene expression in vitro and in vivo. Biochem. Biophys. Res. Commun. 371, 546-550 (2008).
55. Gupta, S., Boppana, R., Mishra, G.C., Saha, B. & Mitra, D. HIV-1 Tat suppresses gp120-specific T cell response in IL-10-dependent manner. J. Immunol. 180, 79-88 (2008).